Evaluation of the clinical practices and awareness of hematologists related to hepatitis B reactivation
| dc.contributor.author | Colkesen, Fatma | |
| dc.contributor.author | Yilmaz, Seda | |
| dc.contributor.author | Duran, Mustafa | |
| dc.date.accessioned | 2022-03-21T14:57:17Z | |
| dc.date.available | 2022-03-21T14:57:17Z | |
| dc.date.issued | 2022 | |
| dc.department | İnönü Üniversitesi | en_US |
| dc.description.abstract | Aim: This study aimed to evaluate the awareness and knowledge of hematologists about hepatitis B virus reactivation (HBVr) to draw attention to this subject's importance. Material and Methods: Sixty-six hematologists included in Turkey. A 13-item questionnaire was administered to the study group to evaluate awareness, knowledge, and experience of HBVr. Results: It was thought by 97% of the participants that all patients who were to receive immunosuppressive treatment (IST) should be screened in respect of HBV. While 98.5% of the hematologists thought HBsAg should be examined in the screening, 89.4% thought anti-HBcIgG should be examined. A total of 89.4% of the hematologists stated that prophylaxis should be started before IST. HBV prophylaxis had been previously administered to patients receiving IST by 97% of the hematologists, and 44% had encountered HBVr at least once in patients. Training related to HBVr after IST had been received following graduation by 75.8% of the hematologists. Conclusions: Awareness about HBVr was found to be high in the hematologists in this study. However, it is worrying that there are clinicians not using anti-HBcIgG test in screening, and the screening rate before treatment with tyrosine kinase inhibitors was low. There was seen to be no standard follow-up protocol either for patients who had started or had not started prophylaxis. This study can be considered to be a stimulus on the subjects of preventing patients with isolated anti-HBcIgG positivity being overlooked, determining the HBVr risk associated with IST, and optimizing the follow-up of patients. | en_US |
| dc.identifier.citation | Colkesen, F., Yilmaz, S., & Duran, M. (2022). Evaluation of the clinical practices and awareness of hematologists related to hepatitis B reactivation. Annals of Medical Research | en_US |
| dc.identifier.uri | https://hdl.handle.net/11616/56747 | |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Annals of Medical Research | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Evaluation of the clinical practices and awareness of hematologists related to hepatitis B reactivation | en_US |
| dc.type | Article | en_US |
